Please assess the completion status of the following clinical trial:

Trial Title: Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children with congenital heart disease undergoing cardiac surgery~* intraoperative aortic cross clamp over 90 minutes or interventional catheterization procedures with post-operative inotrope score over 20~* sign of fluid retention after surgical procedures~Exclusion Criteria:~* Preoperative renal dysfunction~* Preoperative administration of more than 4mg/kg/die loop diuretics~* Need for renal replacement therapy at ICU admission~* Need for ECMO at ICU admission

- Gender: ALL
- Minimum Age: None
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- furosemide (Type: ACTIVE_COMPARATOR): furosemide, 0.2 mg/kg/h up to 0.8 mg/kg/h for 72 hours
- ethacryinic acid (Type: ACTIVE_COMPARATOR): ethacrynic acid, 0.2 mg/kg/h up to 0.8 mg/kg/h for 72 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).